News that the Department of Defense and Department of Homeland Security were ready to plop down $230 million for at-home COVID-19 tests may have been great for the manufacturer, but it could have a deleterious effect on urgent care and other clinical settings that conduct testing—and on the patients the tests are designed to help, as well. The concern is that not all patients will be able to follow the instructions or be physically able …
Read More